#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophilia B without inhibitors Anti-HLA antibody test positive Familial hypertriglyceridaemia Acute respiratory distress syndrome Myeloid leukaemia Acute graft versus host disease Familial haemophagocytic lymphohistiocytosis Hypersomnia Drug eruption Hereditary haemorrhagic telangiectasia Adrenogenital syndrome Nodal marginal zone B-cell lymphoma Vascular malformation Postprandial hypoglycaemia Oropharyngeal cancer recurrent More trials…

    Learn about Rare Diseases

    Short-bowel syndrome – Life with Disease Chondrosarcoma – Basic Information Angiosarcoma metastatic Paroxysmal nocturnal haemoglobinuria Encephalitis autoimmune Activated PI3 kinase delta syndrome – Diagnostics Ewing’s sarcoma – Life with Disease Pleural mesothelioma malignant Idiopathic inflammatory myopathy – Trials in Disease Turner’s syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Exidavnemab Mk-0482 Opevesostat Tiaprofenic Acid Bidridistrogene Xeboparvovec Gadoteridol Testosterone Undecanoate Oxytocin Repagermanium Fosfomycin Bromocriptine Afamitresgene Autoleucel Magnesium Eprosartan Mesilate Vutrisiran Dupilumab Camizestrant Bupropion Hydrochloride ULIXERTINIB Abc-24F-116 More therapies…

    Learn about Your Condition

    Infective uveitis Liver disorder Corticobasal degeneration Pulmonary alveolar haemorrhage Yellow fever External cephalic version Polymyositis Intestinal infarction Bipolar disorder Psoriasis Colorectal cancer stage II Pemphigus Angina pectoris Papillary thyroid cancer Mumps More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study to evaluate the safety and effectiveness of filgotinib in children and adolescents with juvenile idiopathic arthritis.

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Filgotinib
    France Germany

  • Study of pembrolizumab, capecitabine, or olaparib in patients with early-stage triple negative breast cancer and remaining disease after initial treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Capecitabine
    • Gimeracil
    • Olaparib
    The Netherlands

  • A study to evaluate the effectiveness and safety of LAD328 in adults with moderate to severe hidradenitis suppurativa

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Sodium Chloride
    Bulgaria France Germany Poland Spain

  • A study to evaluate the effectiveness and safety of BFB759 in adults with moderate to severe hidradenitis suppurativa

    Recruiting

    2 1
    Bulgaria Czechia Germany Poland Spain

  • A study to evaluate the safety of VTx-002 in patients with amyotrophic lateral sclerosis.

    Recruiting

    2 1 1
    Investigated Drugs:
    • Sodium Dihydrogen Phosphate Dihydrate
    • VTX-002
    Belgium The Netherlands Spain

  • Study of Blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Idarubicin
    • Methotrexate Sodium
    • Crisantaspase
    Austria Belgium Bulgaria Czechia Denmark Estonia +11
Previous Page
1 … 34 35 36 37 38 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!